Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00286143 · ClinicalTrials.gov registry record · Phase 3
Effects of Additional Fentanyl to Epidural Bupivacaine for Post-Thoracotomy Pain in Neonates
A Phase 3 study of Congenital Cystic Adenomatoid Malformation, sponsored by Children's Hospital of Philadelphia.
- Completed
- Registry status
- Phase 3
- Development phase
- 32
- Enrollment target
- 1
- Study location
NCT00286143 is a Phase 3 study of Congenital Cystic Adenomatoid Malformation that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 32 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00286143, a Phase 3 study of Congenital Cystic Adenomatoid Malformation, has completed, sponsored by Children's Hospital of Philadelphia.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 32 participants
- Enrollment target
- 1
- Study location
Study Summary
The study exams whether adding an opioid to the epidural infusion of a local anesthetic in neonates will significantly improve the quality of the postoperative analgesia.
Conditions Studied
Interventions
- DRUG Fentanyl
Study Locations (1)
Pennsylvania
- The Children's Hospital of Philadelphia - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2005-02 |
| Est. Completion | 2007-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00286143
The ClinicalTrials.gov registry entry for NCT00286143 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital of Philadelphia, which has 431 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Congenital Cystic Adenomatoid Malformation appearing as the primary indexed condition, and to 1 intervention - of which Fentanyl is the first listed.
NCT00286143 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00286143 about?
NCT00286143 is a clinical study titled "Effects of Additional Fentanyl to Epidural Bupivacaine for Post-Thoracotomy Pain in Neonates". The study exams whether adding an opioid to the epidural infusion of a local anesthetic in neonates will significantly improve the quality of the postoperative analgesia.
What is the current status of trial NCT00286143?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 32 participants. The study started on 2005-02. Estimated completion is 2007-12.
What conditions does trial NCT00286143 study?
This clinical trial studies the following conditions: Congenital Cystic Adenomatoid Malformation.
What interventions are being tested in trial NCT00286143?
The interventions under investigation include: Fentanyl (DRUG).
Who is sponsoring clinical trial NCT00286143?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00286143 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.